Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin–angiotensin system antagonists

Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes

(2018) Petra Büttner et al.   HEART RHYTHM

Prevalence and predictors of low voltage zones in the left atrium in patients with atrial fibrillation

(2017) Yan Huo et al.   EUROPACE

Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)

(2017) Pamela S. Hair et al.   PLoS One

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPACE

Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis

(2016) Sandip Chaugai et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Myeloperoxidase and Risk of Recurrence of Atrial Fibrillation After Catheter Ablation

(2016) Shuai-bing Li et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Role of Inflammation in Atrial Fibrillation Pathophysiology and Management

(2015) Masahide Harada et al.   CIRCULATION JOURNAL

Atrial remodeling, fibrosis, and atrial fibrillation

(2015) José Jalife et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease

(2015) Anders Lindén et al.   International Journal of Chronic Obstructive Pulmonary Disease

From changes in local RAAS to structural remodeling of the left atrium

(2014) Q. Yongjun et al.   HERZ

Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis

(2012) F. D'Ascenzo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Normal reference values for glomerular filtration rate: what do we really know?

(2012) P. Delanaye et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibrosis in Atrial Fibrillation – Role of Reactive Species and MPO

(2012) Kai Friedrichs et al.   Frontiers in Physiology

Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation

(2010) Volker Rudolph et al.   NATURE MEDICINE